摘要
肝移植是目前最彻底、也是最有效的治疗肝癌的手段。然而，在供肝短缺的困境下如何有效、公平地选择受体仍存在较多争议。“米兰标准”是目前国际上应用最广泛的肝癌肝移植受体筛选标准。近年来，很多超米兰标准（如杭州标准）的患者移植后能取得与符合米兰标准患者相似的移植生存率。该文就肝癌肝移植受体选择标准的研究进展进行介绍。
Liver transplantation is by far the most thorough and effective treatment for liver cancer. However, there is still much controversy about how to select receptors in an effective and equitable manner under the shortage of liver donor. The ＂Milan Standard＂ is the most widely used screening standard for liver transplantation recipients in the world. In recent years, many patients with Trans Milan criteria （such as Hangzhou standard） can achieve transplant survival similar to that of Milan patients after transplantation. This article describes the research progress of liver transplantation recipients＇ selection criteria in hepatocellular carcinoma.
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2018年第2期84-87,共4页
Chinese Journal of Hepatology
基金
国家卫生和计划生育委员会科研基金（2016138643）
浙江省科技厅项目（2015C03034）
关键词
癌
肝细胞
肝移植
米兰标准
选择标准
Carcinoma, hepatocellular
Liver transplantation
Milan criteria
Selection criteria
